Production (Stage)
BIOQUAL, Inc.
BIOQ
$43.19
-$0.25-0.58%
OTC PK
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 62.86M | 61.62M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 62.86M | 61.62M |
| Cost of Revenue | -- | -- | -- | 50.02M | 50.80M |
| Gross Profit | -- | -- | -- | 12.84M | 10.82M |
| SG&A Expenses | -- | -- | -- | 11.93M | 11.77M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | -- | 61.95M | 62.57M |
| Operating Income | -- | -- | -- | 908.50K | -947.60K |
| Income Before Tax | -- | -- | -- | 1.25M | -741.50K |
| Income Tax Expenses | -- | -- | -- | 290.90K | -283.80K |
| Earnings from Continuing Operations | -- | -- | -- | 0.96 | -0.46 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -- | 957.10K | -457.60K |
| EBIT | -- | -- | -- | 908.50K | -947.60K |
| EBITDA | -- | -- | -- | 3.46M | 1.58M |
| EPS Basic | -- | -- | -- | 1.07 | -0.51 |
| Normalized Basic EPS | -- | -- | -- | 0.87 | -0.52 |
| EPS Diluted | -- | -- | -- | 1.06 | -0.52 |
| Normalized Diluted EPS | -- | -- | -- | 0.87 | -0.52 |
| Average Basic Shares Outstanding | -- | -- | -- | 3.58M | 3.58M |
| Average Diluted Shares Outstanding | -- | -- | -- | 3.58M | 3.58M |
| Dividend Per Share | -- | -- | -- | 0.50 | 0.50 |
| Payout Ratio | -- | -- | -- | 46.72% | -97.73% |